Facebook
X
LinkedIn
Forward
Strategies for Improving Medication Adherence
Activity Description
Medication nonadherence is extremely common, especially for individuals with chronic conditions (AMA, 2023). This course provides a summary of common causes of medication non-adherence and provides general techniques for the healthcare team to improve medication adherence and associated health outcomes.
Target Audience
Learning Objectives
- Review background of adherence measures
- Discuss costs of non-adherence
- Identify common causes for non-adherence
- Recognize general techniques for improving adherence
- Examine medication-specific strategies for improving adherence in select classes
| Name | Role | Disclosure of Relevant Financial Relationships with Ineligible Company |
|---|---|---|
Shelby Schroeder Social Worker | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Charles Jin Physician | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Byanka Romero-Williams Nurse | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Mandy Lin Other | Other non-licensed training | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Kari Muskopf Occupational Therapist | Other licensed training | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Alison Sutton Pharmacist | Planner & Speaker | No relevant financial relationship(s) with ineligible companies to disclose |
Nancy Laux Pharmacist | Planner & Speaker | Nancy has an Ownership Interest for Merck and relevant financial relationships have been mitigated. Nancy has an Ownership Interest for Organon and relevant financial relationships have been mitigated. |
Ife Adeleye Pharmacist | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Saneel Kulkarni Pharmacist | Independent Reviewer | No relevant financial relationship(s) with ineligible companies to disclose |
Disclosures of relevant financial relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, Centene Institute for Advanced Health Education (Centene Institute) requires all those in control of educational content to disclose their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling or distributing health care products used by or on patients. Individuals must disclose all financial relationships, regardless of the amount, with ineligible companies and regardless of their view of the relevance of the relationship to the education. Centene Institute ensures that the content is independent of commercial bias.
None of the Centene Institute staff members have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Universal Activity Number UAN JA4008309-0000-23-005-H01-P/T
Available Credit
- 1.00 ACPE Pharmacy
- 1.00 ACPE Technician
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Attendance/Participation
Since CE boards may have changes in requirements, it is the responsibility of the attendee to verify with their boards if they accept the CEs being offered.
Required Hardware/software
Please ensure you are using the web-browser Chrome and disable any pop-up blocking software.